Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 17, Issue 4, April 1992

MONOGRAPHS

CGP 28014. COMT inhibitor. H.J. Möbius, G. von Sprecher and P.C. Waldmeier

Exemestane. Aromatase inhibitor. E. di Salle and T. Zaccheo

KPS-107. Topical antiinflammatory steroid. H.P. Kim

L-697,661. Antiviral, HIV-1 reverse transcriptase inhibitor. J.S. Wai and M.E. Goldmann

OPC-17116. Fluoroquinolone antibacterial

Pramipexole Hydrochloride. Dopamine D2 agonist. L- de Angelis, J. Castañer and J. Prous

YM-175. Antiresorptive

REVIEW ARTICLES

Development of novel anti-oncoprotein therapies for the clinical management of cancer patients M.H. Goyns

Recent advances toward novel bradykinin antagonists D.J. Kyle and R.M. Burch

Information Update 1-16

Acivicin
Actisomide
AJ-2615
Bemitradine
BMY-21502
Butenafine Hydrochloride
Cefpirome
Cericlamine Hydrochloride
Clospipramine Hydrochloride
Cloturin
CN-100
CY-208-243
Desflurane
Dideoxyadenosine
Ditiocarb Sodium Trihydrate
DuP-753
E-6123
Edelfosine
Epalrestat
Famciclovir
FCE-22891
Fleroxacin
Gallium Nitrate
Imazodan Hydrochloride
ImuVert
Inaperisone Hydrochloride
Isomazole Hydrochloride
KB-2796
L-659989
L44-O
Lacidipine
Loreclezole
LY-134046
McN-5691
MK-507
Nanterinone
NB-818
NC-1100
ONO-RS-411
Penciclovir
Pentamorphone
Pirmenol Hydrochloride
Polyene Phosphatidylcholine
Ponalrestat
Rifapentine
Rimcazole Hydrochloride
RS-5142
Sobuzoxane
Sorbinil
SQ-29548
Terguride
Tiazofurine
Trimelamol
Trospectomycin Sulfate
Vinconate
YM-12617-1
Zindoxifene


 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy